Literature DB >> 15350535

Wrch1 is a GTPase-deficient Cdc42-like protein with unusual binding characteristics and cellular effects.

Jan Saras1, Patrick Wollberg, Pontus Aspenström.   

Abstract

The Rho family of small GTPases controls many biological processes, including cytoskeletal regulation, membrane trafficking, cell adhesion, cell polarization, transcriptional activity, apoptosis, and cell proliferation. Wrch1, which belongs to the Cdc42 subfamily, is one of the least characterized family member. Despite its homology to other Cdc42-like proteins, we found that Wrch1 has unique characteristics. Biochemical experiments showed that Wrch1 has no detectable GTPase activity in vitro and that its intrinsic nucleotide exchange rate is very high in comparison to Cdc42. Furthermore, NIH3T3 cells transiently transfected with Wrch1 showed an up-rounded, retracted phenotype. In addition, Wrch1 was shown to be more efficient than Cdc42 in triggering the formation of filopodia. Serum stimulation of cells expressing Wrch1 induces vigorous membrane blebbing, a phenomenon dependent on the activity of ROCK. In a search for proteins interacting with Wrch1, PAK1 and NCKbeta were identified as binding partners. Interestingly, the interaction to NCKbeta was shown to be mediated via PxxP motifs present in an N-terminal extension of Wrch1 to the second and third SH3 domains of NCKbeta. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350535     DOI: 10.1016/j.yexcr.2004.05.029

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  26 in total

1.  Cdc42 is not essential for filopodium formation, directed migration, cell polarization, and mitosis in fibroblastoid cells.

Authors:  Aleksandra Czuchra; Xunwei Wu; Hannelore Meyer; Jolanda van Hengel; Timm Schroeder; Robert Geffers; Klemens Rottner; Cord Brakebusch
Journal:  Mol Biol Cell       Date:  2005-07-12       Impact factor: 4.138

2.  The atypical Rho GTPase Wrch1 collaborates with the nonreceptor tyrosine kinases Pyk2 and Src in regulating cytoskeletal dynamics.

Authors:  Aino Ruusala; Pontus Aspenström
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

3.  The transforming Rho family GTPase Wrch-1 disrupts epithelial cell tight junctions and epithelial morphogenesis.

Authors:  Donita C Brady; Jamie K Alan; James P Madigan; Alan S Fanning; Adrienne D Cox
Journal:  Mol Cell Biol       Date:  2008-12-08       Impact factor: 4.272

Review 4.  Importance of RhoGTPases in formation, characteristics, and functions of invadosomes.

Authors:  Pirjo Spuul; Paolo Ciufici; Véronique Veillat; Anne Leclercq; Thomas Daubon; IJsbrand Kramer; Elisabeth Génot
Journal:  Small GTPases       Date:  2014-05-08

Review 5.  Fast-cycling Rho GTPases.

Authors:  Pontus Aspenström
Journal:  Small GTPases       Date:  2018-01-29

6.  Regulation of the Rho family small GTPase Wrch-1/RhoU by C-terminal tyrosine phosphorylation requires Src.

Authors:  Jamie K Alan; Anastacia C Berzat; Brian J Dewar; Lee M Graves; Adrienne D Cox
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 7.  Pleiotropic functions of Rho GTPase signaling: a Trojan horse or Achilles' heel for breast cancer treatment?

Authors:  P R McHenry; T Vargo-Gogola
Journal:  Curr Drug Targets       Date:  2010-09       Impact factor: 3.465

8.  The regulation of osteoclast function and bone resorption by small GTPases.

Authors:  Cecile Itzstein; Fraser P Coxon; Michael J Rogers
Journal:  Small GTPases       Date:  2011-05

Review 9.  Rho GTPases: Regulation and roles in cancer cell biology.

Authors:  Raquel B Haga; Anne J Ridley
Journal:  Small GTPases       Date:  2016-09-14

10.  The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathways.

Authors:  Davide Schiavone; Sarah Dewilde; Francesco Vallania; James Turkson; Ferdinando Di Cunto; Valeria Poli
Journal:  Biochem J       Date:  2009-06-26       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.